1. 1. Yuta A, Ogawa Y, Suzuki Y, et al. [Clinical efficacy of sublingual immunotherapy in the third treated year with Japanese cedar pollinosis in 2017]. Arerugi [Allergy]. 2017;66:1172-80. Japanese.
2. 2. Caruso M, Cibella F, Emma R, et al. Basophil biomarkers as useful predictors for sublingual immunotherapy in allergic rhinitis. Int Immunopharmacol. 2018;60:50-8.
3. 3. Sakashita M, Makino Y, Noguchi E, Hirota T, Tamari M, Fujieda S. [Clinical relevance of biomarkers in allergic rhinitis]. Arerugi [Allergy]. 2014;63:767-74. Japanese.
4. 4. Ciprandi G, Silvestri M. Serum specific IgE: a biomarker of response to allergen immunotherapy. J Investig Allergol Clin Immunol. 2014;24:35-9.
5. 5. Kaminuma O, Gotoh M, Nakaya A, Okubo K, Hiroi T. [A biomarker set relation to the efficacy of allergen-specific immunotherapy]. Nihon Yakurigaku Zasshi [Folia Pharmacol Jap]. 2015;146:259-62. Japanese.